Back to Results
First PageMeta Content
Organic chemistry / Thyroid hormone / Thyronamine / Endocrine system / Oregon Health & Science University / 3-Iodothyronamine / Thyroid / Metabolism / Anatomy / Chemistry / Biogenic amines


NEWS RELEASE For Immediate Release IKARIA Announces In-Licensing of “Thyronamine Technology” from the University of California, San Francisco and Oregon Health & Science University Ikaria, a Seattle biotechnology com
Add to Reading List

Document Date: 2011-06-28 11:53:09

Open Document

File Size: 68,01 KB

Share Result on Facebook

City

Seattle / /

Company

Ikaria / Health & Science University Ikaria / Chemical Biology Laboratories / /

Facility

Science University / Fred Hutchinson Cancer Research Center / University of California / /

IndustryTerm

biotechnology / natural products / energy metabolism / thyronamine technology / /

MedicalCondition

metabolic depression / hypothermia / heart attack / diseases / bradycardia / cardiac arrest / human injuries / human disease / /

MedicalTreatment

major surgery / /

Organization

University of California / School of Medicine / Department of Physiology & Pharmacology / University of California / San Francisco / Oregon Health & Science University / Fred Hutchinson Cancer Research Center / /

Person

Thomas Scanlan / Csaba Szabo / David Grandy / Mark Roth / /

Position

investigator / Chief Scientific Officer / Director / scientist / Director of the Program / /

ProvinceOrState

California / /

Technology

biotechnology / thyronamine technology / /

URL

www.ikaria.com / /

SocialTag